Fw. Flynn et Me. Smith, LATERAL VENTRICULAR INJECTIONS OF THE NK3 AGONIST SENKTIDE AFFECT SALT TASTE-ELICITED RESPONSES, Peptides, 19(2), 1998, pp. 319-324
Central injections of the selective tachykinin NK3 receptor agonist se
nktide (SENK) suppresses salt appetite. Also, following SENK, intraora
l infusions of hypertonic NaCl elicit fewer ingestive taste reactivity
responses and more aversive responses than following intraventricular
injections of isotonic saline. This pattern of taste reactivity resul
ts suggest that SENK affects the oral stimulating properties of salt t
aste. Before accepting this interpretation, however, alternative expla
nations need to be examined. The following experiments evaluated wheth
er the effects of intraventricular SENK injection on taste reactivity
could be due to: 1) a general oral motor impairment that reduces inges
tive responding to tastes (Experiment 1) or; 2) SENK having aversive c
onsequences (Experiment 2). In Experiment 1, the effects of intraventr
icular injections of SENK (200 ng) on taste reactivity responses to 0.
5 M NaCl and 0.1 M sucrose were measured in sodium deficient rats. Int
raoral infusions of 0.5 M NaCl elicited fewer ingestive taste reactivi
ty responses following SENK than injections of isotonic saline in sodi
um deficient rats. Sucrose continued to elicit the same high number of
ingestive taste reactivity responses following intraventricular injec
tions of isotonic saline and SENK. Thus, SENK did not cause a general
decrease in ingestive responding. A conditioned taste aversion test wa
s employed in Experiment 2 to determine if SENK had aversive consequen
ces. Rats were given 30 min access to alanine (0.3 M) and were then ad
ministered either lithium chloride (LiCl) or intraventricular injectio
ns of SENK (200 ng) on three consecutive days. Rats avoided alanine th
at was paired with LiCl, but those rats that had alanine paired with S
ENK showed no avoidance of the taste even after three pairings. These
results replicate findings that intraventricular injections of the NK3
agonist SENK decreases the palatability of NaCl (as measured by taste
reactivity) and suggest that its effect on NaCl-elicited taste reacti
vity is not due to the treatment causing a motor impairment or malaise
. (C) 1998 Elsevier Science Inc.